Selected Industry Projects

• Antihypertensive agents: amlodipine, ramipril – Phase 3 reports

• Anti-infectives: azithromycin, linezolid – Phase 3 reports, quality control

• Antiplatelet agent: clopidogrel – Phase 1 reports
  

• Antithrombotic: factor Xa inhibitor – Phase 1 reports

• Breast cancer: fulvestrant – Informed consent document

• Diabetes: troglitazone – Phase 3 reports

• Esophageal cancer: nimotuzumab – Protocol

• Global Innovate!! Implementation of progressive business ideas

• Hormone replacement: norethindrone acetate/ethinyl estradiol – Phase 3 reports

• Hypercholesterolemia: torcetrapib / atorvastatin – Phase 2 reports

• Neuropathic pain: gabapentin, pregabalin – Phase 3 reports, safety narratives

• Progressive familial intrahepatic cholestasis (PFIC): odevixibat – Phase 3 report, Modules 2.7.3, 2.7.4

• Renal disease: mycophenolate sodium – Protocol

• Selective estrogen receptor modulator (SERM): lasofoxifene – Phase 2/3 reports

• Smoking cessation: varenicline – Phase 3 reports

• Workshops: Clinical Study Reports, GCP, ICH and the Declaration of Helsinki, Informed Consent, Search Strategies, Statistics in Medicine.